Back to trial details

Intake questionnaire

Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer

Applying to Froedtert Hospital & the Medical College of Wisconsin · Milwaukee, Wisconsin

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer?
3. Are you able to travel to Milwaukee for study visits?